Skip to main content

In the Beginning, There Was Serendipity

  • Reference work entry
Drug Design

Abstract

“A lucky accident dropped the medicine into our hands”; this is how a publication on August 14, 1886, from Arnold Cahn and Paul Hepp in the Centralblatt für Klinische Medizin began. The history of drug research is punctuated by lucky accidents. As a general rule, detailed knowledge of biological systems was absent. So it is not surprising that the working hypotheses were often wrong, and the obtained results differed from the expectations. The case of accidental success fell into the background over time. Today happenstance as a strategy has been replaced by the arduous and ambitious goal of preparing drugs by using a straightforward approach. The only exception to this is the kind of shotgun-style testing of large and diverse chemical compound libraries, including microbial and plant extracts that is done with the goal of finding new lead structures. In this case, serendipity is desired to find as large and diverse a palette of lead structures (Chaps. 6, “The Classical Search for Lead Structures” and 7, “Screening Technologies for Lead Structure Discovery”) with potential for further optimization (Chaps. 8, “Optimization of Lead Structures” and 9, “Designing Prodrugs”).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 649.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 949.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Bibliography

Primary Literature

  • Ban TA (2006) The role of serendipity in drug discovery. Dialogues Clin Neurosci 8:335–344

    PubMed  Google Scholar 

  • Burger A (1983) A guide to the chemical basis of drug design. Wiley, New York

    Google Scholar 

  • de Stevens G (1986) Serendipity and structured research in drug discovery. Fortschr Arzneimittelforsch 30:189–203

    Google Scholar 

  • Kubinyi H (1999) Chance favors the prepared mind. From serendipity to rational drug design. J Receptor Signal Transd Res 19:15–39

    Article  CAS  Google Scholar 

  • Restak RM (1994) Receptors. Bantam Books, New York

    Google Scholar 

  • Roberts RM (1989) Serendipity. Accidental discoveries in science. Wiley, New York

    Google Scholar 

  • Sneader W (1990) Chronology of drug introductions. In: Hansch C, Sammes PG, Taylor JB (eds) Comprehensive medicinal chemistry, vol 1, Kennewell PD (ed). Pergamon Press, Oxford, S.7–S.80

    Google Scholar 

Secondary Literature

  • Cahn A, Hepp P (1886) Das Antifebrin, ein neues Fiebermittel. Centralblatt für Klinische Medizin 7:561–564

    Google Scholar 

  • Hofmann A (1993) LSD – mein Sorgenkind, dtv/Klett-Cotta

    Google Scholar 

  • Sternbach LH (1978) The Benzodiazepine story. Fortschr Arzneimittelforsch 22:229–266

    CAS  Google Scholar 

  • Stütz A (1987) Allylamine derivatives – a new class of active substances in antifungal chemotherapy. Angew Chem Int Ed 26:320–328

    Article  Google Scholar 

  • von Vámossy Z (1900) Ist Phenolphthalein ein unschädliches Mittel zum Kenntlichmachen von Tresterweinen? Chemiker-Zeitung 24:679–680

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag Berlin Heidelberg

About this entry

Cite this entry

Klebe, G. (2013). In the Beginning, There Was Serendipity. In: Klebe, G. (eds) Drug Design. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-17907-5_2

Download citation

Publish with us

Policies and ethics